Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (6): 346-349.
Previous Articles Next Articles
Sun Yiyuan1, Deng Jianxiong2, Yang Yue1,*
Received:
2017-05-05
Revised:
2017-08-17
Online:
2017-06-20
Published:
2017-08-17
CLC Number:
Sun Yiyuan, Deng Jianxiong, Yang Yue. Application of Improved Weighted Association Rule Algorithm in Identifying the Risk of Pharmaceutical Production[J]. Chinese Journal of Pharmacovigilance, 2017, 14(6): 346-349.
[1] Agrawal R, Srikant R. Fast algorithms for mining association rules[C]. Readings in database systems. Morgan Kaufmann Publishers Inc,1998:487-499 [2] 安颖. 基于Apriori算法的兴趣集加权关联规则挖掘[J]. 北京联合大学学报(自然科学版),2008,4(74):44-47. [3] 张秋凤. 加权关联规则挖掘算法研究及应用[D].天津师范大学,2011. [4] 国家食品药品监督管理局.药品和医疗器械安全突发事件应急预案(试行)[Z].国食药监办[2011]370号. [5] 楼宜嘉. 药物毒理学[M]. 2版,北京:人民卫生出版社, 2007. [6] 张娜. 基于灰色理论与关联规则的中药注射剂不良反应成因研究[D]. 北京中医药大学,2010. [7] 王超,叶小飞,钱维,等. 药品不良反应信号检测中的关联规则[J]. 中国药物警戒,2010,7(3):145-147 [8] 冯变玲,魏芬,杨世民,等. 心脑血管用药不良反应与用药人群间的关联关系分析[J]. 中国药房,2011,22(36):3389-3391. [9] 黄堪瑜. 省级ADR系统的信息智能分析与数据挖掘方法研究[D].广东工业大学,2011. [10] 冯秀珍,贺小红,冯变玲. 基于关联规则的ADR预警系统及实证研究[J]. 科技管理研究,2012,9(46):194-197. [11] 杨薇,谢雁鸣,向永洋. 基于SRS数据的舒血宁注射液不良反应关联分析[J]. 中国中药杂志,2014,39(18):3616-3620. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||